TIRZEPATIDE GAINING FIRST MOVERS ADVANTAGE First developed to control type 2 diabetes, both tirzepatide (Mounjaro) and semaglutide (Wegovy) are prescription drugs that mimic natural gut hormones to reduce caloric intake by influencing appetite control mechanisms
They can ache, itch and sometimes need surgery
What You Get With Freya Fast 3 Day Shipping One-On-One Nutritionist Sessions No Hidden Fees, Lock-Ins or Price Changes Fast 3 Day Shipping One-On-One Nutritionist Sessions No Hidden Fees, Lock-Ins or Price Changes Fast 3 Day Shipping One-On-One Nutritionist Sessions No Hidden Fees, Lock-Ins or Price Changes Monthly Freya Community Calls Cancel Anytime LegitScript Certified Comprehensive Doctor + Nurse Support Monthly Freya Community Calls Cancel Anytime LegitScript Certified Comprehensive Doctor + Nurse Support Monthly Freya Community Calls Cancel Anytime LegitScript Certified Comprehensive Doctor + Nurse Support FAQs How quickly will I see results
The SELECT cardiovascular outcomes trial (Lincoff et al., 2023, New England Journal of Medicine) enrolled 17,604 adults with obesity and established cardiovascular disease no diabetes, and demonstrated a 20% reduction in major adverse cardiovascular events (MACE) with 2.4mg semaglutide versus placebo
The trial lasted for 26 weeks, giving the drug ample time to reach its maximum dosage in the patients systems
Before comparing them in detail, its important to understand what type of medicines they are